Analyst Consensus ?
ConsensusBuy37 ratings
Bullish2978.4%
Neutral718.9%
Bearish12.7%
FN2 Earnings Intelligence
Ecolab Inc. analyst ratings
Ecolab Inc. (ECL) analyst consensus, price targets, and firm-level rating history from FN2 Research.
Analyst 52W Price Targets
$291.27Current
$164Low
$279.24Average
$426High
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Oct 28, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| UBS | Buy | Buy | Maintain | Oct 5, 2026 |
| Wells Fargo | Equal Weight | Equal Weight | Maintain | Jul 30, 2026 |
| Mizuho | Outperform | Outperform | Maintain | Jul 29, 2026 |
| JP Morgan | Overweight | Overweight | Maintain | Jul 29, 2026 |
| BMO Capital | Outperform | Outperform | Maintain | Jul 29, 2026 |
| Oppenheimer | Outperform | Perform | Upgrade | Jul 17, 2026 |
| Deutsche Bank | Buy | Buy | Maintain | Jul 9, 2026 |
| RBC Capital | Outperform | Outperform | Maintain | Jul 7, 2026 |
| Citigroup | Buy | Buy | Maintain | Jun 24, 2026 |
| Jefferies | Buy | Buy | Maintain | May 20, 2026 |
| B of A Securities | Buy | Buy | Maintain | Apr 21, 2026 |
| Baird | Outperform | Outperform | Maintain | Mar 24, 2026 |
| Evercore ISI Group | Outperform | Outperform | Maintain | Feb 18, 2026 |
| Exane BNP Paribas | Outperform | Outperform | Maintain | Feb 12, 2026 |
| BNP Paribas | Outperform | Outperform | Maintain | Feb 12, 2026 |
| Stifel | Buy | Buy | Maintain | Feb 11, 2026 |
| Barclays | Overweight | Overweight | Maintain | Oct 29, 2025 |
| Seaport Global | Buy | Neutral | Upgrade | Apr 21, 2025 |
| Redburn Atlantic | Neutral | Buy | Downgrade | Mar 24, 2025 |
| Piper Sandler | Overweight | Overweight | Maintain | Feb 24, 2025 |
| Morgan Stanley | Overweight | Equal Weight | Upgrade | Jan 28, 2025 |
| Raymond James | Outperform | Outperform | Maintain | Apr 3, 2024 |
| Northcoast Research | Neutral | Buy | Downgrade | Jul 5, 2023 |
| Credit Suisse | Outperform | Outperform | Maintain | Nov 7, 2022 |
| Argus Research | Buy | Buy | Maintain | May 31, 2022 |
| Edward Jones | Buy | Hold | Upgrade | Mar 17, 2022 |
| Gabelli & Co. | Buy | Hold | Upgrade | Jan 15, 2021 |
| CFRA | Hold | Hold | Maintain | Apr 30, 2020 |
| Stifel Nicolaus | Hold | Hold | Maintain | Feb 19, 2020 |
| Nomura | Buy | Buy | Maintain | Aug 7, 2019 |
| Citi | Neutral | Neutral | Maintain | Aug 2, 2019 |
| Canaccord Genuity | Buy | Buy | Maintain | May 1, 2019 |
| Longbow Research | Neutral | Buy | Downgrade | Feb 22, 2017 |
| Macquarie | Outperform | Outperform | Maintain | Aug 25, 2016 |
| Goldman Sachs | Sell | Sell | Maintain | Aug 3, 2016 |
| Sterne Agee CRT | Buy | Buy | Maintain | Mar 22, 2016 |
| PiperJaffray | Overweight | Overweight | Maintain | Nov 3, 2015 |
Named analyst price targets
Upside is calculated against the persisted current price $291.27. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| UBS | Joshua Spector | $344 | $273.7 | +18.1% | Oct 5, 2026 |
| UBS | Joshua Spector | $342 | $281.05 | +17.4% | Jul 29, 2026 |
| BMO Capital | John McNulty | $360 | $280.58 | +23.6% | Jul 29, 2026 |
| Mizuho Securities | Analyst unavailable | $327 | $282.9 | +12.3% | Jul 29, 2026 |
| Robert W. Baird | Andrew Wittmann | $305 | $282.9 | +4.7% | Jul 29, 2026 |
| Oppenheimer | Scott Schneeberger | $320 | $275.71 | +9.9% | Jul 17, 2026 |
| Deutsche Bank | Analyst unavailable | $335 | $272.13 | +15.0% | Jul 9, 2026 |
| Wells Fargo | Jason Hass | $275 | $264.44 | -5.6% | Jun 10, 2026 |
| UBS | Joshua Spector | $325 | $254.23 | +11.6% | May 27, 2026 |
| Jefferies | Analyst unavailable | $345 | $250.22 | +18.4% | May 20, 2026 |
| UBS | Analyst unavailable | $293 | $272.47 | +0.6% | Apr 9, 2026 |
| Evercore ISI | Analyst unavailable | $312 | $305 | +7.1% | Feb 18, 2026 |
| Deutsche Bank | David Begleiter | $325 | $300.28 | +11.6% | Feb 13, 2026 |
| BMO Capital | John McNulty | $345 | $300.69 | +18.4% | Feb 13, 2026 |
| Seaport Global | Analyst unavailable | $340 | $304.59 | +16.7% | Feb 12, 2026 |
| UBS | Analyst unavailable | $312 | $300.56 | +7.1% | Feb 11, 2026 |
| Morgan Stanley | Analyst unavailable | $330 | $300.64 | +13.3% | Feb 11, 2026 |
| Mizuho Securities | Analyst unavailable | $335 | $299.62 | +15.0% | Feb 11, 2026 |
| Robert W. Baird | Andrew Wittmann | $327 | $299.62 | +12.3% | Feb 11, 2026 |
| Stifel Nicolaus | Analyst unavailable | $337 | $299.62 | +15.7% | Feb 11, 2026 |
| UBS | Analyst unavailable | $295 | $270.96 | +1.3% | Jan 7, 2026 |
| Evercore ISI | Eric Boyes | $300 | $256.4 | +3.0% | Nov 3, 2025 |
| UBS | Analyst unavailable | $291 | $256.18 | -0.1% | Oct 31, 2025 |
| BMO Capital | John McNulty | $307 | $260.56 | +5.4% | Oct 30, 2025 |
| Mizuho Securities | John Roberts | $315 | $268.28 | +8.1% | Oct 29, 2025 |
| Stifel Nicolaus | Analyst unavailable | $300 | $265.41 | +3.0% | Oct 29, 2025 |
| Robert W. Baird | Analyst unavailable | $307 | $268.28 | +5.4% | Oct 29, 2025 |
| Barclays | Manav Patnaik | $300 | $268.28 | +3.0% | Oct 29, 2025 |
| UBS | Joshua Spector | $299 | $278.91 | +2.7% | Oct 6, 2025 |
| BMO Capital | John McNulty | $310 | $275.35 | +6.4% | Sep 8, 2025 |
| Jefferies | Andrew Andersen | $426 | $265.09 | +46.3% | Jul 30, 2025 |
| Wells Fargo | Jason Haas | $260 | $262.38 | -10.7% | May 20, 2025 |
| Robert W. Baird | Andrew Wittmann | $277 | $253.66 | -4.9% | Apr 2, 2025 |
| UBS | Joshua Spector | $276 | $244.5 | -5.2% | Nov 4, 2024 |
| BMO Capital | John McNulty | $279 | $254.46 | -4.2% | Oct 30, 2024 |
| Citigroup | Pat Cunningham | $292 | $253.76 | +0.3% | Oct 29, 2024 |
| Morgan Stanley | Vincent Andrews | $240 | $254.26 | -17.6% | Oct 29, 2024 |
| Jefferies | Laurence Alexander | $310 | $257.1 | +6.4% | Oct 18, 2024 |
| Wells Fargo | Jason Haas | $295 | $251.02 | +1.3% | Oct 7, 2024 |
| Piper Sandler | Charles Neivert | $305 | $254.82 | +4.7% | Sep 26, 2024 |
| RBC Capital | Ashish Sabadra | $306 | $250.54 | +5.1% | Sep 16, 2024 |
| Mizuho Securities | John Roberts | $291 | $250.87 | -0.1% | Sep 3, 2024 |
| Wells Fargo | Jason Haas | $270 | $237.24 | -7.3% | Aug 12, 2024 |
| Bank of America Securities | Steve Byrne | $272 | $228.86 | -6.6% | Jul 31, 2024 |
| Deutsche Bank | David Begleiter | $245 | $228.86 | -15.9% | Jul 31, 2024 |
| Citigroup | Pat Cunningham | $265 | $228.86 | -9.0% | Jul 31, 2024 |
| UBS | Joshua Spector | $282 | $242.84 | -3.2% | Jul 9, 2024 |
| Stifel Nicolaus | Shlomo Rosenbaum | $283 | $238.19 | -2.8% | Jul 8, 2024 |
| RBC Capital | Ashish Sabadra | $260 | $234.69 | -10.7% | May 21, 2024 |
| UBS | Joshua Spector | $270 | $234.69 | -7.3% | May 21, 2024 |
| BMO Capital | John McNulty | $234 | $224.84 | -19.7% | May 1, 2024 |
| Mizuho Securities | John Roberts | $260 | $220.75 | -10.7% | Apr 12, 2024 |
| Piper Sandler | Charles Neivert | $260 | $227.45 | -10.7% | Apr 3, 2024 |
| Barclays | Manav Patnaik | $260 | $222.09 | -10.7% | Feb 28, 2024 |
| RBC Capital | Ashish Sabadra | $213 | $188.61 | -26.9% | Jul 18, 2023 |
| Mizuho Securities | Christopher Parkinson | $177 | $173.36 | -39.2% | May 3, 2023 |
| Wells Fargo | Analyst unavailable | $168 | $152.72 | -42.3% | Jan 13, 2023 |
| Citigroup | Analyst unavailable | $164 | $150.44 | -43.7% | Dec 15, 2022 |
| Deutsche Bank | David Begleiter | $135 | $142.98 | -53.7% | Nov 2, 2022 |
| RBC Capital | Ashish Sabadra | $190 | $162.77 | -34.8% | Jul 26, 2022 |
| Credit Suisse | John Roberts | $195 | $148.17 | -33.1% | Jun 20, 2022 |
| UBS | Joshua Spector | $205 | $145.63 | -29.6% | Jun 17, 2022 |
| Mizuho Securities | Christopher Parkinson | $198 | $169.34 | -32.0% | Apr 29, 2022 |
| J.P. Morgan | Analyst unavailable | $190 | $168.47 | -34.8% | Apr 27, 2022 |
| Atlantic Equities | Colin Isaac | $210 | $182.95 | -27.9% | Apr 10, 2022 |
| Bank of America Securities | Steve Byrne | $196 | $177.59 | -32.7% | Mar 25, 2022 |
| Deutsche Bank | David Begleiter | $210 | $178.64 | -27.9% | Feb 20, 2022 |
| RBC Capital | Ashish Sabadra | $225 | $182.22 | -22.8% | Feb 16, 2022 |
| Credit Suisse | Kevin Mcveigh | $215 | $182.22 | -26.2% | Feb 16, 2022 |
| Robert W. Baird | Andrew Wittmann | $198 | $182.66 | -32.0% | Feb 15, 2022 |
| Mizuho Securities | Chris Parkinson | $210 | $182.66 | -27.9% | Feb 15, 2022 |
| Goldman Sachs | Robert Koort | $194 | $194.46 | -33.4% | Jan 21, 2022 |
| Evercore ISI | Stephen Richardson | $235 | $219.64 | -19.3% | Dec 3, 2021 |
| Vertical Research | Kevin McCarthy | $189 | $217.1 | -35.1% | Sep 27, 2021 |
Track every rating change on ECL the moment it posts. Free to start.
Start freeGet the ECL recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.